Search Thermo Fisher Scientific
- Order Status
- Quick Order
-
Don't have an account ? Create Account
Search Thermo Fisher Scientific
We are committed to helping you accelerate the downstream purification of your vaccines. Explore our key considerations for implementing resins in various vaccine modalities, such as protein subunits, virus-like particles, and viral vectors.
Learn how the Jenner Institute uses affinity tags to streamline malaria vaccine development.
Learn how a novel affinity chromatograph resin contributes to fast, efficient, and scalable mRNA purification.
Read the conversation between thought-leaders from both the mRNA vaccine and therapeutics spheres as they share a unique cross-pollination of manufacturing experiences and ideas between both worlds.
Read to understand how an integrated system of tools for protein expression, affinity purification, and quality control testing can help support efficient and cost-effective virus like particle production on a commercial scale.
Read to learn how the C-tag affinity tag system is applied as a standard purification process for candidate malaria vaccines to support efficient translation into clinical trials.
Read to discover how novel chromatography solutions and analytical testing can help improve the downstream processes of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).
Explore recent developments in the purification of various vaccine modalities such as VLPs, mRNA, and protein subunits, through this collection of articles.
Gain more insights into various vaccine modalities and how they are efficiently purified through this collection of articles, webinars, and infographics.
Learn how to implement an efficient downstream purification process and avoid bottlenecks in the manufacturing of vaccines and new modalities.
Expand your knowledge on purification tools used for rapid candidate screening and intensified downstream processing of vaccine modalities.
Watch a conversation between thought-leaders from both the mRNA vaccine and therapeutics spheres as they share a unique cross-pollination of manufacturing experiences and ideas between both worlds.
Understand how affinity chromatography can aid vaccine development and manufacturing by improving purification of vaccine modalities such as mRNA and protein subunits.
Watch to understand how an integrated system of tools for protein expression, affinity purification, and quality control testing can help support efficient and cost-effective virus-like particle production on a commercial scale.
Watch to learn how the C-tag affinity tag system is applied as a standard purification process for candidate malaria vaccines to support efficient translation into clinical trials.
Watch to discover how novel chromatography solutions and analytical testing can help improve the downstream processes of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).
Learn how novel purification solutions can help improve the downstream process of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).
For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.